XWELL, Inc. (NASDAQ:XWEL) Sees Large Increase in Short Interest

XWELL, Inc. (NASDAQ:XWEL) saw a large increase in short interest in the month of January. As of January 30th, there was short interest totaling 226,787 shares, an increase of 219.9% from the January 15th total of 70,903 shares. Currently, 4.6% of the company’s shares are short sold. Based on an average daily volume of 1,899,514 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 1,899,514 shares, the days-to-cover ratio is presently 0.1 days. Currently, 4.6% of the company’s shares are short sold.

XWELL Price Performance

Shares of NASDAQ XWEL opened at $0.47 on Friday. XWELL has a 1-year low of $0.26 and a 1-year high of $1.42. The company has a market capitalization of $2.71 million, a price-to-earnings ratio of -0.14 and a beta of 1.51. The business has a 50-day moving average of $0.50 and a 200-day moving average of $0.83.

XWELL (NASDAQ:XWEL) last posted its earnings results on Friday, November 14th. The company reported ($0.26) EPS for the quarter. The firm had revenue of $7.35 million for the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 51.85%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of XWELL in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, XWELL has a consensus rating of “Sell”.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.